This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hauptschein, R. S. Articles by Jay, D. G. Search for Related Content PubMed PubMed Citation Articles by Hauptschein, R. S. Articles by Jay, D. G.

Functional Proteomic Screen Identifies a Modulating Role for CD44 in Death Receptor–Mediated Apoptosis

¹ Department of Physiology, Tufts University School of Medicine, Boston, Massachusetts and ² Xerion Pharmaceuticals, AG, Munich, Germany

Requests for reprints: Daniel G. Jay, Department of Physiology, Tufts University School of Medicine, 7th Floor, M&V Building, 136 Harrison Avenue, Boston, MA 02111. Phone: 617-636-6714; Fax: 617-636-0445; E-mail: daniel.jay{at}tufts.edu.

Apoptotic evasion is a hallmark of cancer and its resistance to chemotherapeutic drugs. Identification of cellular proteins that mediate apoptotic programs is a critical step toward the development of therapeutics aimed at overcoming apoptosis resistance. We developed an innovative high-throughput screen to identify proteins that modulate Fas ligand–mediated apoptosis using fluorophore-assisted light inactivation (HTS-FALIpop). The FALI protein knockdown strategy was coupled to a caspase activity assay with the ability to detect both proapoptotic and antiapoptotic surface molecules expressed by HT-1080 human fibrosarcoma cells. FALI of the Fas receptor (Fas/CD95) using a fluorescein-conjugated anti-Fas antibody abrogated Fas ligand–mediated caspase activation. Ninety-six single-chain variable fragment antibodies (scFv), selected for binding to the surface of HT-1080 cells, were screened by HTS-FALIpop. Three of the scFvs caused decreases in caspase induction after FALI of their protein targets. One of the targets of these positive scFvs was identified as CD44 and was validated by performing FALI using a CD44-specific monoclonal antibody, which resulted in similar protection from Fas apoptosis. CD44-targeted FALI was antiapoptotic in multiple human cancer cell lines, including both Fas signaling type I and II cells, and was also protective against other ligands of the tumor necrosis factor death receptor family. FALI of CD44 inhibited formation and activation of the death-inducing signaling complex, suggesting that CD44 regulates Fas at the cell surface. This mechanism of death receptor regulation represents a novel means of apoptosis modulation that could be exploited by pharmacologic agents.

Key Words: functional proteomics • apoptosis • CD44 • fluorophore-assisted light inactivation • death receptor

This article has been cited by other articles:

				J. Zeilstra, S. P.J. Joosten, M. Dokter, E. Verwiel, M. Spaargaren, and S. T. Pals Deletion of the WNT Target and Cancer Stem Cell Marker CD44 in Apc(Min/+) Mice Attenuates Intestinal Tumorigenesis Cancer Res., May 15, 2008; 68(10): 3655 - 3661. [Abstract] [Full Text] [PDF]

				S. Wang, S. Wang, H. Maeng, D. P. Young, O. Prakash, L. E. Fayad, A. Younes, and F. Samaniego K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis Blood, March 1, 2007; 109(5): 2174 - 2182. [Abstract] [Full Text] [PDF]

				J. Guo, H. Chen, H. L. Puhl III, and S. R. Ikeda Fluorophore-assisted light inactivation produces both targeted and collateral effects on N-type calcium channel modulation in rat sympathetic neurons J. Physiol., October 15, 2006; 576(2): 477 - 492. [Abstract] [Full Text] [PDF]

				Y. Wang, Q.-Y. He, R. W.-Y. Sun, C.-M. Che, and J.-F. Chiu Gold(III) Porphyrin 1a Induced Apoptosis by Mitochondrial Death Pathways Related to Reactive Oxygen Species Cancer Res., December 15, 2005; 65(24): 11553 - 11564. [Abstract] [Full Text] [PDF]